Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079596332> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2079596332 endingPage "532" @default.
- W2079596332 startingPage "526" @default.
- W2079596332 abstract "Since only approx. 30% of patients with ovarian carcinoma present themselves in the early stages, and as a result of the lack of effective screening methods, primary interest has been applied to the improvement of the treatment quality in the later stages. Improvement of therapeutic strategies implies an adaptation of specific characteristics of the patient and the tumour. For instance, in cases of primary progression during chemotherapy, it is not justified to continue an aggressive treatment, which causes additional serious side effects. Surprisingly, it has not been possible, to utilize established or suspected prognostic factors for treatment strategies in ovarian cancer. This might result, in part, from the uncertainty of criteria such as stage of disease, residual tumour and histological grading. The single most relevant prognostic factor today is the residual tumour mass. In 1988 van der Burg suggested for the first time a potential prognostic relevance of the CA 125 half-life. This study was designed, to investigate the use of CA 125 half-life in therapeutic strategies. From January 1984 to June 1990, 346 patients with primary ovarian cancer were treated at our institution. Preoperative CA 125 levels were determined in 292 patients; in 220 patients the levels were complete for a period of more than 6 months so that the CA 125 half-life could be calculated. Survival times of patients with a half-life of less than 20 days were significantly (p less than 0.0001) different from patients with a half-life of more than 20 days.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2079596332 created "2016-06-24" @default.
- W2079596332 creator A5002412211 @default.
- W2079596332 creator A5025963329 @default.
- W2079596332 creator A5057153061 @default.
- W2079596332 creator A5073318979 @default.
- W2079596332 creator A5084392138 @default.
- W2079596332 date "1992-09-01" @default.
- W2079596332 modified "2023-09-23" @default.
- W2079596332 title "Prognostische Bedeutung der CA 125-Halbwertszeit für den weiteren Krankheitsverlauf beim Ovarialkarzinom" @default.
- W2079596332 doi "https://doi.org/10.1055/s-2007-1023174" @default.
- W2079596332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1397953" @default.
- W2079596332 hasPublicationYear "1992" @default.
- W2079596332 type Work @default.
- W2079596332 sameAs 2079596332 @default.
- W2079596332 citedByCount "5" @default.
- W2079596332 countsByYear W20795963322015 @default.
- W2079596332 crossrefType "journal-article" @default.
- W2079596332 hasAuthorship W2079596332A5002412211 @default.
- W2079596332 hasAuthorship W2079596332A5025963329 @default.
- W2079596332 hasAuthorship W2079596332A5057153061 @default.
- W2079596332 hasAuthorship W2079596332A5073318979 @default.
- W2079596332 hasAuthorship W2079596332A5084392138 @default.
- W2079596332 hasConcept C121608353 @default.
- W2079596332 hasConcept C126322002 @default.
- W2079596332 hasConcept C127413603 @default.
- W2079596332 hasConcept C143998085 @default.
- W2079596332 hasConcept C146357865 @default.
- W2079596332 hasConcept C147176958 @default.
- W2079596332 hasConcept C151730666 @default.
- W2079596332 hasConcept C159110408 @default.
- W2079596332 hasConcept C2776694085 @default.
- W2079596332 hasConcept C2777286243 @default.
- W2079596332 hasConcept C2779134260 @default.
- W2079596332 hasConcept C2779951463 @default.
- W2079596332 hasConcept C2780427987 @default.
- W2079596332 hasConcept C29456083 @default.
- W2079596332 hasConcept C3019054536 @default.
- W2079596332 hasConcept C71924100 @default.
- W2079596332 hasConcept C86803240 @default.
- W2079596332 hasConcept C90924648 @default.
- W2079596332 hasConceptScore W2079596332C121608353 @default.
- W2079596332 hasConceptScore W2079596332C126322002 @default.
- W2079596332 hasConceptScore W2079596332C127413603 @default.
- W2079596332 hasConceptScore W2079596332C143998085 @default.
- W2079596332 hasConceptScore W2079596332C146357865 @default.
- W2079596332 hasConceptScore W2079596332C147176958 @default.
- W2079596332 hasConceptScore W2079596332C151730666 @default.
- W2079596332 hasConceptScore W2079596332C159110408 @default.
- W2079596332 hasConceptScore W2079596332C2776694085 @default.
- W2079596332 hasConceptScore W2079596332C2777286243 @default.
- W2079596332 hasConceptScore W2079596332C2779134260 @default.
- W2079596332 hasConceptScore W2079596332C2779951463 @default.
- W2079596332 hasConceptScore W2079596332C2780427987 @default.
- W2079596332 hasConceptScore W2079596332C29456083 @default.
- W2079596332 hasConceptScore W2079596332C3019054536 @default.
- W2079596332 hasConceptScore W2079596332C71924100 @default.
- W2079596332 hasConceptScore W2079596332C86803240 @default.
- W2079596332 hasConceptScore W2079596332C90924648 @default.
- W2079596332 hasIssue "09" @default.
- W2079596332 hasLocation W20795963321 @default.
- W2079596332 hasLocation W20795963322 @default.
- W2079596332 hasOpenAccess W2079596332 @default.
- W2079596332 hasPrimaryLocation W20795963321 @default.
- W2079596332 hasRelatedWork W167319750 @default.
- W2079596332 hasRelatedWork W1987468340 @default.
- W2079596332 hasRelatedWork W2064014472 @default.
- W2079596332 hasRelatedWork W2111918063 @default.
- W2079596332 hasRelatedWork W2312713041 @default.
- W2079596332 hasRelatedWork W2362789976 @default.
- W2079596332 hasRelatedWork W2381681474 @default.
- W2079596332 hasRelatedWork W2417262672 @default.
- W2079596332 hasRelatedWork W2910125853 @default.
- W2079596332 hasRelatedWork W2981964168 @default.
- W2079596332 hasVolume "52" @default.
- W2079596332 isParatext "false" @default.
- W2079596332 isRetracted "false" @default.
- W2079596332 magId "2079596332" @default.
- W2079596332 workType "article" @default.